Journal of Geriatric Psychiatry and Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Free Access - Register Here

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoeh, N.
Right arrow Articles by Streim, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoeh, N.
Right arrow Articles by Streim, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Geriatric Psychiatry and Neurology, Vol. 16, No. 4, 213-218 (2003)
DOI: 10.1177/0891988703258663
© 2003 SAGE Publications

Pharmacologic Management of Psychosis in the Elderly: A Critical Review

Nicholas Hoeh, MD

nickhoeh{at}yahoo.com

Laszlo Gyulai, MD

Daniel Weintraub, MD

Joel Streim, MD

University of Pennsylvania, Philadelphia

Objective.Psychotic symptoms are seen in numerous psychiatric illnesses afflicting the elderly. This article reviews the efficacy of the pharmacologic management of psychotic symptoms in primary psychotic disorders, affective disorders, and neurodegenerative disorders. Method.A comprehensive literature review. Results.Evidence to support the use of pharmacologic interventions to manage psychotic symptoms in elderly patients afflicted with primary psychotic disorders and affective disorders is limited by the absence of randomized, placebo-controlled trials (RCTs). The use of low-dose clozapine is supported by RCTs in Parkinson’s disease. The efficacy of risperidone and olanzapine for the treatment of psychotic symptoms has been demonstrated by large RCTs in Alzheimer’s disease. Conclusion.There is evidence of the efficacy of antipsychotic medications to manage psychotic symptoms in elderly patients. However, the absence of published evidence from RCTs in primary psychotic and affective disorders, and the limited evidence in the neurodegenerative illnesses, is notable.

Key Words: geriatric • elderly • psychosis • psychotropic • review


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Geriatr Psychiatry NeurolHome page
D. V. Jeste, T. W. Meeks, D. S. Kim, and G. S. Zubenko
Research Agenda for DSM-V: Diagnostic Categories and Criteria for Neuropsychiatric Syndromes in Dementia
J Geriatr Psychiatry Neurol, September 1, 2006; 19(3): 160 - 171.
[Abstract] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
S. Karim and E. J. Byrne
Treatment of psychosis in elderly people
Advan. Psychiatr. Treat., July 1, 2005; 11(4): 286 - 296.
[Abstract] [Full Text] [PDF]